Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bakkt (BKKT) Gains from Investment Securities (2020 - 2025)

Bakkt (BKKT) has 6 years of Gains from Investment Securities data on record, last reported at $23.1 million in Q3 2025.

  • For Q3 2025, Gains from Investment Securities rose 480.8% year-over-year to $23.1 million; the TTM value through Sep 2025 reached -$537000.0, up 85.9%, while the annual FY2023 figure was -$3.0 million, N/A changed from the prior year.
  • Gains from Investment Securities reached $23.1 million in Q3 2025 per BKKT's latest filing, up from $8.6 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $23.1 million in Q3 2025 and bottomed at -$32.2 million in Q1 2025.
  • Average Gains from Investment Securities over 5 years is -$3.2 million, with a median of -$2.4 million recorded in 2022.
  • The widest YoY moves for Gains from Investment Securities: up 4333.61% in 2024, down 2935.51% in 2024.
  • A 5-year view of Gains from Investment Securities shows it stood at -$22.4 million in 2021, then skyrocketed by 50.91% to -$11.0 million in 2022, then soared by 65.44% to -$3.8 million in 2023, then crashed by 59.31% to -$6.1 million in 2024, then surged by 480.8% to $23.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Gains from Investment Securities were $23.1 million in Q3 2025, $8.6 million in Q2 2025, and -$32.2 million in Q1 2025.